OmarAl UstwaniMD

PubMed

• 1 citations
  Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective anal...
  Harry Menon, Adip Pillai, Jeanine Aussenberg-Rodriguez, John Ambrose, Irini Youssef, Elizabeth A. Griffiths, Omar Al Ustwani> ;Avicenna Journal of Medicine. 2018 Oct 1
• 17 citations
  Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia
  Pallawi Torka, Omar Al Ustwani, Meir Wetzler, Eunice S. Wang, Elizabeth A. Griffiths> ;Blood Reviews. 2016 May 1
• 22 citations
  Clinical updates in adult acute lymphoblastic leukemia.
  Omar Al Ustwani, Neha Gupta, Hatoon Bakhribah, Elizabeth A. Griffiths, Eunice S. Wang, Meir Wetzler> ;Critical Reviews in Oncology/hematology. 2016 Mar 1
• 14 citations
  Omacetaxine mepesuccinate in chronic myeloid leukemia
  Omar Al Ustwani, Elizabeth A. Griffiths, Eunice S. Wang, Meir Wetzler> ;Expert Opinion on Pharmacotherapy. 2014 Oct 10
• 6 citations
  Bing–Neel Syndrome in a Patient with Waldenstrom's Macroglobulinemia: A Challenging Diagnosis in the Face of Normal Brain Imaging
  Neha Gupta, Sahil Gupta, Omar Al Ustwani, Venkata K. Pokuri, Hassan Hatoum, Seema A. Bhat> ;CNS Neuroscience & Therapeutics. 2014 Oct 1
• 23 citations
  Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer.
  Neha Gupta, Omar Al Ustwani, Li Shen, Roberto Pili> ;Oncotargets and Therapy. 2014 Feb 12
• 52 citations
  Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review
  Omar Al Ustwani, James W. Lohr, Grace K. Dy, Charles LeVea, Gregory C. Connolly, Pradeep Arora, Renuka Iyer> ;Journal of Gastrointestinal Oncology. 2014 Feb 1
• 32 citations
  Genetics on a WHIM
  Omar Al Ustwani, Razelle Kurzrock, Meir Wetzler> ;British Journal of Haematology. 2014 Jan 1
• 9 citations
  Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
  Sofa Ghani, Omar Al-Ustwani, Bilal Khalid, Paul N. Bogner, Marcelle A. Grassi, Jennifer Powell, Seema A. Bhat> ;Clinical Advances in Hematology & Oncology. 2013 Oct 1
• 55 citations
  Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature
  Omar Al Ustwani, Laurie A. Ford, Sheila J.N. Sait, Anne Marie W. Block, Maurice Barcos, Carlos E. Vigil, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang, Mei...> ;Leukemia Research. 2013 Aug 1
• 2 citations
  Homoharringtonine and granulocyte colony-stimulating factor priming for acute myeloid leukemia: is it ready for prime time?
  Omar Al Ustwani, Meir Wetzler> ;Leukemia & Lymphoma. 2013 Feb 14
• 1 citations
  The use of low-dose protracted oral clofarabine in a patient with myelodysplastic syndrome after failing 5-azacitidine.
  Omar Al Ustwani, Jessica D. Greene, Meir Wetzler> ;Leukemia Research Reports. 2013 Jan 1
• 2 citations
  Multiple cranial nerve palsies as the initial presentation of peripheral T-cell lymphoma.
  Guy A. Weiss, Omar Al-Ustwani, Regina Makdissi> ;Clinical Advances in Hematology & Oncology. 2012 Sep 1
• 37 citations
  Detection of circulating tumor cells in cancers of biliary origin.
  Omar Al Ustwani, Dan Iancu, Rabi Yacoub, Renuka Iyer> ;Journal of Gastrointestinal Oncology. 2012 Jun 1
• 20 citations
  Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells.
  Omar Al Ustwani, Jawad Francis, Paul K. Wallace, Meir Wetzler> ;Leukemia Research. 2011 Jan 17
• Join now to see all